ClinVar Genomic variation as it relates to human health
NM_000152.5(GAA):c.2284G>A (p.Glu762Lys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000152.5(GAA):c.2284G>A (p.Glu762Lys)
Variation ID: 456399 Accession: VCV000456399.16
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 17q25.3 17: 80117062 (GRCh38) [ NCBI UCSC ] 17: 78090861 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 26, 2017 Feb 7, 2023 Sep 6, 2022 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000152.5:c.2284G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000143.2:p.Glu762Lys missense NM_001079803.3:c.2284G>A NP_001073271.1:p.Glu762Lys missense NM_001079804.3:c.2284G>A NP_001073272.1:p.Glu762Lys missense NC_000017.11:g.80117062G>A NC_000017.10:g.78090861G>A NG_009822.1:g.20507G>A LRG_673:g.20507G>A LRG_673t1:c.2284G>A - Protein change
- E762K
- Other names
- -
- Canonical SPDI
- NC_000017.11:80117061:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00002
The Genome Aggregation Database (gnomAD) 0.00001
Exome Aggregation Consortium (ExAC) 0.00002
The Genome Aggregation Database (gnomAD), exomes 0.00002
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
GAA | - | - |
GRCh38 GRCh38 GRCh37 |
2805 | 2857 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (7) |
criteria provided, multiple submitters, no conflicts
|
Sep 6, 2022 | RCV000534884.17 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Feb 15, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type II
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000789527.1
First in ClinVar: Dec 26, 2017 Last updated: Dec 26, 2017 |
|
|
Uncertain significance
(May 01, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type II
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001281477.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. (less)
|
|
Uncertain significance
(Sep 05, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type II
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV002027301.1
First in ClinVar: Nov 29, 2021 Last updated: Nov 29, 2021 |
|
|
Uncertain significance
(Jan 22, 2020)
|
criteria provided, single submitter
Method: curation
|
Glycogen storage disease, type II
(Autosomal recessive inheritance)
Affected status: unknown
Allele origin:
germline
|
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Accession: SCV001422806.2
First in ClinVar: Jul 19, 2020 Last updated: Feb 01, 2022 |
Comment:
The p.Glu762Lys variant in GAA has been reported in one individual with Glycogen Storage Disease II (PMID: 21488291). This variant has also been reported as … (more)
The p.Glu762Lys variant in GAA has been reported in one individual with Glycogen Storage Disease II (PMID: 21488291). This variant has also been reported as a VUS by Invitae and Counsyl in ClinVar (Variation ID: 456399). This variant has been identified in 0.003% (1/30780) of South Asian chromosomes and 0.003% (3/111366) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs760063214). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. However, the Glutamate (Glu) at position 762 is not highly conserved in mammals and evolutionary distant species, and 15 species (elephant, saker falcon, peregrine falcon, collared flycatcher, white-throated sparrow, medium ground finch, zebra finch, Tibetan ground jay, budgerigar, scarlet macaw, mallard duck, chicken, turkey, American alligator, and green sea turtle) carry a Lysine (Lys), raising the possibility that this change at this position may be tolerated. In summary, the clinical significance of the p.Glu762Lys variant is uncertain. ACMG/AMP Criteria applied: PM2 (Richards 2015). (less)
|
|
Uncertain significance
(Nov 17, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type II
Affected status: yes
Allele origin:
germline
|
MGZ Medical Genetics Center
Accession: SCV002580372.1
First in ClinVar: Oct 15, 2022 Last updated: Oct 15, 2022
Comment:
ACMG criteria applied: PM2_SUP, BP4
|
Number of individuals with the variant: 1
Sex: male
|
|
Uncertain significance
(Sep 06, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Glycogen storage disease, type II
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000626560.3
First in ClinVar: Dec 26, 2017 Last updated: Feb 07, 2023 |
Comment:
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 762 of the GAA protein … (more)
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 762 of the GAA protein (p.Glu762Lys). This variant is present in population databases (rs760063214, gnomAD 0.003%). This missense change has been observed in individual(s) with unspecified clinical presentation who showed low levels of acid alpha-glucosidase activity (PMID: 21488291). ClinVar contains an entry for this variant (Variation ID: 456399). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GAA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
|
Uncertain significance
(Feb 09, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Glycogen storage disease type II
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV002092122.1
First in ClinVar: Apr 23, 2022 Last updated: Apr 23, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Novel human pathological mutations. Gene symbol: GAA. Disease: glycogen storage disease 2. | Niu DM | Human genetics | 2010 | PMID: 21488291 |
https://erepo.clinicalgenome.org/evrepo/ui/interpretation/81c4283f-d34a-436e-a3c2-e3000458cd75 | - | - | - | - |
Text-mined citations for rs760063214 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.